Although most samples examined in this study were from patients diagnosed as disease-free (69 samples from 9 patients), and the number of samples from patients diagnosed with disease recurrence should be increased in future work from our preliminary results, expressions of the ER in the CTM from patients with breast cancer during follow-up visits could be variable and inconsistent with examinations in original records. The gene discussed is ESR1; the disease is breast carcinoma.